Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Gastroenterology
|
December 28, 1999
Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting
N Chalasani, W S Clark, L G Martin, et al.
Alimentary Pharmacology & Therapeutics
|
September 7, 2010
Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network
R Vuppalanchi, P H Hayashi, N Chalasani, et al.
The American Journal of Gastroenterology
|
November 24, 1999
Predictors of large esophageal varices in patients with cirrhosis
N Chalasani, T F Imperiale, A Ismail, et al.
Alimentary Pharmacology & Therapeutics
|
March 10, 2012
Serum proteomic profiling in patients with drug-induced liver injury
L N Bell, R Vuppalanchi, P B Watkins, et al.
The American Journal of Gastroenterology
|
October 16, 1999
Screening for hepatocellular carcinoma in patients with advanced cirrhosis
N Chalasani, J C Horlander, A Said, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
November 8, 2001
Increase in hepatic arterial blood flow after transjugular intrahepatic portosystemic shunt creation and its potential predictive value of postprocedural encephalopathy and mortality
N H Patel, K J Sasadeusz, R Seshadri, et al.
Hepatology (Baltimore, Md.)
|
December 29, 1999
Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study
N Chalasani, A Baluyut, A Ismail, et al.
Alimentary Pharmacology & Therapeutics
|
November 19, 2016
Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis
E Vilar-Gomez, L Calzadilla-Bertot, S L Friedman, et al.
Alimentary Pharmacology & Therapeutics
|
April 27, 2018
Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease
N Chalasani, R Vuppalanchi, M Rinella, et al.
Alimentary Pharmacology & Therapeutics
|
October 26, 2016
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis
S A Harrison, S R Marri, N Chalasani, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Gastroenterology
|
December 28, 1999
Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting
N Chalasani, W S Clark, L G Martin, et al.
Alimentary Pharmacology & Therapeutics
|
September 7, 2010
Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network
R Vuppalanchi, P H Hayashi, N Chalasani, et al.
The American Journal of Gastroenterology
|
November 24, 1999
Predictors of large esophageal varices in patients with cirrhosis
N Chalasani, T F Imperiale, A Ismail, et al.
Alimentary Pharmacology & Therapeutics
|
March 10, 2012
Serum proteomic profiling in patients with drug-induced liver injury
L N Bell, R Vuppalanchi, P B Watkins, et al.
The American Journal of Gastroenterology
|
October 16, 1999
Screening for hepatocellular carcinoma in patients with advanced cirrhosis
N Chalasani, J C Horlander, A Said, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
November 8, 2001
Increase in hepatic arterial blood flow after transjugular intrahepatic portosystemic shunt creation and its potential predictive value of postprocedural encephalopathy and mortality
N H Patel, K J Sasadeusz, R Seshadri, et al.
Hepatology (Baltimore, Md.)
|
December 29, 1999
Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study
N Chalasani, A Baluyut, A Ismail, et al.
Alimentary Pharmacology & Therapeutics
|
November 19, 2016
Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis
E Vilar-Gomez, L Calzadilla-Bertot, S L Friedman, et al.
Alimentary Pharmacology & Therapeutics
|
April 27, 2018
Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease
N Chalasani, R Vuppalanchi, M Rinella, et al.
Alimentary Pharmacology & Therapeutics
|
October 26, 2016
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis
S A Harrison, S R Marri, N Chalasani, et al.
Page
of 5